Suppression by 17β-estradiol of monocyte adhesion to vascular endothelial cells is mediated by estrogen receptors

Life Sciences

Volumn 75, Issue 5, 2004, Pages 599-609

  Mori, Michiko ^a   Tsukahara, Fujiko ^a   Yoshioka, Toshimasa ^a   Irie, Kaoru ^a   Ohta, Hiroaki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

17 estradiol; Estrogen receptor; Estrogen replacement therapy; NF B; VCAM 1

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; ESTRADIOL RECEPTOR; MESSENGER RNA;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; ESTROGEN THERAPY; HUMAN; HUMAN CELL; INHIBITION KINETICS; MONOCYTE; PROTEIN FUNCTION; UPREGULATION; VASCULAR ENDOTHELIUM; BIOSYNTHESIS; CELL LINE; CELL STRAIN U937; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL ADHESION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ESTRADIOL; GENE EXPRESSION REGULATION; HUMANS; MONOCYTES; NF-KAPPA B; RECEPTORS, ESTRADIOL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 85047692733     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.12.023     Document Type: Article

References (26)

1. Agostino V., Lorenzo G., Maurizio L., Felica P., Andrea G., Simona B., Stefano T., Antonio S. Mechanism responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women. Circulation. 101:2000;2258-2263
2. Bush T.L., Barrett-Connor E., Cowarn L.D., Criqui M.H., Wallace R.B., Suchindran C.M., Tyroler H.A., Rifkind B.M. Cardiocascular mortality and uncontraceptive estrogen use in women: results from the Lipid Research Clinics program Follow-up Study. Ciculation. 75(6):1987;1102-1109
3. Caulin-Glaser T., Watson C.A., Pardi R., Bender J.R. Effects of 17β-estradiol on cytokine-induced endothelial cell adhesion molecule expression. Journal Clinnical Investigation. 98(1):1996;36-42
4. Colditz G.A., Willett W.C., Stampfer M.J., Rosner B., Speizer F.E., Hennekens C.H. Menopause and the risk of coronary heart disease in women. New England Journal Medicine. 316(18):1987;1105-1110
5. Couse J., Lindzey J., Grandien K., Gustasson J., Korach K. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ER alpha) and estrogen receptor-beta (ER beta) messenger ribonucleic acid in the wild-type and ER alpha-knockout mouse. Endocrinology. 138:1997;4613-4621
6. De Caterina R., Gimbrone M.A. Jr. Leukocyte-endothelial interactions and the pathogenesis of atherosclerosis. Prevention and Treatment in Vascular Disease. 1995;9-24 Springer Verlag, London, UK
7. Gilligan D.M., Bardar D.M., Panza J.A., Quyyumi A.A., Cannon R.O. III Acute vascular effect of estrogen in postmenopausal women. Circulation. 90(2):1994;786-791
8. Grodstein F., Stampfer M.J., Colditz G.A., Willett W.C., Manson J.E., Joffe M., Rosner B., Fuchs C., Hamkinson S.E., Hunter D.J., Hennekens C.H., Speizer F.E. Postmenopausal hormone therapy and mortality. New England Journal Medicine. 336(25):1997;1769-1775
9. Herrington D.M., Braden G.A., Williams J.K., Morgan T.M. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. American Journal Cardiology. 73(13):1994;951-952
10. Izumi Y., Taniuchi Y., Tsuji T., Smith C.W., Nakamori S., Fildler I.J., Irimura T. Characterization of human colon carcinoma variant cells selected for sialyl Le carbohydrate antigen: Liver colonization and adhesion to vascular endothelial cells. Experimental Cell Research. 216:1995;215-221
11. Krasinski K., Spyridopoulos I., Asahara T., Zee R., Isner J.M., Losordo D.W. Estradiol accelerates functional endothelial recovery after arterial injury. Circulation. 95:1997;1768-1772
12. Kuiper G.G.J.M., Carlsson B., Grandien K.A.J., Enmark E., Haggblad J., Nilsson S., Gustafsson J.-A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β Endocrinology. 138:1997;863-870
13. Lieberman E.H., Gerhard M.D., Uehara A., Walsh B.W., Selwyn A.R., Ganz P., Yeung A.C., Creager M.A. Estrogen improves endothelial-dependent, flow-mediated vasodilatation in postmenopausal women. Annual International Medicine. 121(12):1994;936-941
14. Losordo D.W., Keaney M., Kim E.A., Jekanowski J., Isner J.M. Variable expression of estrogen receptor in normal and atherosclerotic coronary arteries of postmenopausal women. Circulation. 89(4):1994;1501-1510
15. Pervin S., Sigh R., Rosenfeld M.E., Navab M., Chandhuri G., Nathan L. Estradiol suppresses MCP-1expression in vivo: implications for atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 18(10):1998;1575-1582
16. Ross R. Atherosclerosis is an imflammatory disease. American Heart Journal. 138(5pt2):1999;S419-S420
17. Sack M.N., Rader D.J., Cannon R.O. III Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenapausal women. Lancet. 343(8892):1994;269-270
18. Sairam M.R., Darilovich N., Lussier-Cacans S. The FORKO mouse as a genetic model for exploring estrogen replacement therapy. Journal Reprodctive Medicine. 47(5):2002;412-418
19. Simoncini T., De Carerina R., Genazzani A.R. Selective estrogen receptor modulators: different actions on vascular cell adhesion molecule-1 (VCAM-1) ex18 ression in human endothelial cells. The Journal Clinical Endocrinology and Metabolism. 84(12):1999;815-818
20. Simoncini T., Maffei S., Basta G., Barsacchi G., Ganazzani A.R., Liao J.K., Caterina R.D. Estrogen and glucocorticoids inhibit endothelial vascular cell adhesion molecular-1 expression by different transcriptional mechanisms. Circulation Research. 87:2000;19-25
21. Stampfer M.J., Golditz G.A., Willett W.C., Manson J.E., Rosner B., Speizer F.E., Hennekens C.M. Postmenopausal therapy and cardiovascular disease: ten-years follow-up from Nurses' Health Study. New England Journal Medicine. 325(11):1991;756-762
22. Vane J.R., Auggard E.E., Botting R.M. Regulatory functions of the vascular endothelium. New England Journal Medicine. 323(4):1990;27-35
23. Willson M.E., Rosewell K.L., Kashon M.L., Shughrue P.J., Merchenthaler I., Wise P.M. Age differentially influences estrogen receptor-alpha and estrogen receptor-beta gene expression in specific regions of the rat brains. Mechanisms of Ageing and Development. 123(6):2002;593-601
24. Wiseman H., O'Reilly J. Molecular action of oestrogens in the prevention of cardiovascular disease. Oestrogen as antioxidant cardioprotectants. Biochem Society Transactions. 25:1996;54-59
25. Writing Group for the Women's Health Initiative Investigators Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 288:2002;321-333
26. Yamada Y., Ando F., Niino W., Ohta S., Shimokawa H. Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density of the femoral neck in elderly Japanese women. Journal of Molecular Medicine. 80(7):2002;452-460